CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 241 enrolled
Drug / intervention
Investigational Healon5 OVD +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02782676
NCT02782676N/ACompleted
CompareCT.gov

Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD)

Abbott Medical Optics·interventional·Posted May 25, 2016·Updated Feb 4, 2025

In Brief

A clinical study evaluating Investigational Healon5 OVD and Healon5 OVD for Cataract. Completed, enrolled 241 participants.

Detailed Summary

Prospective, multicenter, paired-eye, randomized, masked, clinical trial of the bacterially-derived Healon5 OVD versus the currently available Healon5 OVD control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 25, 2016
Enrollment StartJun 21, 2016
Primary CompletionMay 4, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.1 years ago

Interventions

Investigational Healon5 OVDdevice

ophthalmic viscosurgical device

Healon5 OVDdevice

ophthalmic viscosurgical device